Torthaí cuardaigh - Maria I. Carlo

Beachtaigh na torthaí
  1. 1
    Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis

    Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis de réir Maria I. Carlo, Darren R. Feldman

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma

    Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma de réir Maria I. Carlo, Martin H. Voss, Robert J. Motzer

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer

    Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer de réir James J. Hsieh, Brandon J. Manley, Nabeela Khan, Jianjiong Gao, Maria I. Carlo, Emily H. Cheng

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

    A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma de réir Maria I. Carlo, Ana M. Molina, Yulia Lakhman, Sujata Patil, Kaitlin M. Woo, John DeLuca, Chung‐Han Lee, James J. Hsieh, Darren R. Feldman, Robert J. Motzer, Martin H. Voss

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes

    Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes de réir Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Mark T.A. Donoghue, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Martin H. Voss, Robert J. Motzer

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights

    Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights de réir Maria I. Carlo, A. Ari Hakimi, Grant D. Stewart, Gennady Bratslavsky, James Brugarolas, Ying‐Bei Chen, W. Marston Linehan, Eamonn R. Maher, Maria J. Merino, Kenneth Offit, Victor E. Reuter, Brian Shuch, Jonathan Coleman

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes

    Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes de réir Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Jozefina Casuscelli, Almedina Redzematovic, Renzo G. DiNatale, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Robert J. Motzer, Martin H. Voss

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes

    Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes de réir Maria I. Carlo, Joshua Chaim, Sujata Patil, Yelena Kemel, Alison M. Schram, Kaitlin M. Woo, Devyn Taylor Coskey, Gouri J. Nanjangud, Martin H. Voss, Darren R. Feldman, James J. Hsieh, A. Ari Hakimi, Ying‐Bei Chen, Robert J. Motzer, Chung‐Han Lee

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases

    Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases de réir Liwei Jia, Maria I. Carlo, Hina Khan, Gouri J. Nanjangud, Satshil Rana, Robert Cimera, Yanming Zhang, A. Ari Hakimi, Amit Verma, Hikmat Al‐Ahmadie, Samson W. Fine, Anuradha Gopalan, S. Joseph Sirintrapun, Satish K. Tickoo, Victor E. Reuter, Benjamin A. Gartrell, Ying‐Bei Chen

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

    Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma de réir Maria I. Carlo, Brandon J. Manley, Sujata Patil, Kaitlin M. Woo, Devyn Taylor Coskey, Almedina Redzematovic, Maria E. Arcila, Marc Ladanyi, Won-Jae Lee, Ying‐Bei Chen, Chung‐Han Lee, Darren R. Feldman, A. Ari Hakimi, Robert J. Motzer, James J. Hsieh, Martin H. Voss

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy

    DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy de réir Yasser Ged, Joshua Chaim, Renzo G. DiNatale, Andrea Knežević, Ritesh R. Kotecha, Maria I. Carlo, Chung‐Han Lee, Ashley A. Foster, Darren R. Feldman, Min Yuen Teo, Gopa Iyer, Timothy A. Chan, Sujata Patil, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations

    Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations de réir Diana Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, Joshua Somar, Miika Mehine, Maksym Misyura, Olca Baştürk, Alicia Latham, Maria I. Carlo, Michael F. Walsh, Zsofia K. Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge S. Reis‐Filho, Ozge Ceyhan‐Birsoy

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders de réir Alice Boilève, Maria I. Carlo, Philippe Barthélémy, Stéphane Oudard, Delphine Borchiellini, Martin H. Voss, Saby George, Christine Chevreau, Judith Landman‐Parker, M-D Tabone, D. D. Chism, A. Amin, Mehmet Asım Bilen, Dominick Bossé, Aurore Coulomb‐L'Herminé, Xiaoping Su, Toni K. Choueiri, Nizar M. Tannir, Gabriel G. Malouf

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy

    Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy de réir Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, Sounak Gupta, Onur Yıldırım, Samuel Murray, Devyn Taylor Coskey, Ritesh R. Kotecha, Chung‐Han Lee, Darren R. Feldman, Paul Russo, Sujata Patil, Robert J. Motzer, Jonathan Coleman, Jeremy C. Durack, Ying‐Bei Chen, Oğuz Akın, A. Ari Hakimi, Martin H. Voss

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates de réir Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Ying‐Bei Chen, Mark Zucker, Andrea Knežević, Robert A. Lefkowitz, Natalie Shapnik, Chloe Dadoun, Ed Reznik, Neil J. Shah, Colette Owens, Deaglan Joseph McHugh, David H. Aggen, Andrew Leonard Laccetti, Ritesh R. Kotecha, Darren R. Feldman, Robert J. Motzer

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers de réir Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley Marie Regazzi, Brooke Kania, Meredith Moran, C Cipolla, Mark J. Bluth, Joshua Chaim, Hikmat Al‐Ahmadie, Alexandra Snyder, Maria I. Carlo, David B. Solit, Michael F. Berger, Samuel A. Funt, Jedd D. Wolchok, Gopa Iyer, Dean F. Bajorin, Margaret K. Callahan, Jacob Rosenberg

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

    Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing de réir Panieh Terraf, Fresia Pareja, David Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana, Eileen M. O’Reilly, Maria I. Carlo, Carol Aghajanian, Ying L. Liu, Fatemeh Derakhshan, Gowtham Jayakumaran, Britta Weigelt, Michael F. Walsh, Zsofia K. Stadler, Kenneth Offit, Marc Ladanyi, Mark E. Robson, Ahmet Zehir, Jorge S. Reis‐Filho, Diana Mandelker

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma

    Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma de réir Jozefina Casuscelli, Maria F. Becerra, Brandon J. Manley, Emily C. Zabor, Ed Reznik, Almedina Redzematovic, Maria E. Arcila, Daniel Tennenbaum, Mazyar Ghanaat, Mahyar Kashan, Christian G. Stief, Maria I. Carlo, Martin H. Voss, Darren R. Feldman, Robert J. Motzer, Ying‐Bei Chen, Victor E. Reuter, Jonathan Coleman, Paul Russo, James J. Hsieh, A. Ari Hakimi

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

    Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma de réir Jack P. Gleeson, Ines Nikolovski, Renzo G. DiNatale, Mark Zucker, Andrea Knežević, Sujata Patil, Yasser Ged, Ritesh R. Kotecha, Natalie Shapnik, Samuel Murray, Paul Russo, Jonathan Coleman, Chung‐Han Lee, Zsofia K. Stadler, A. Ari Hakimi, Darren R. Feldman, Robert J. Motzer, Ed Reznik, Martin H. Voss, Ying‐Bei Chen, Maria I. Carlo

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer

    Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer de réir Jada G. Hamilton, Heather Symecko, Kelsey Spielman, Kelsey Breen, Rebecca Mueller, Amanda Catchings, Magan Trottier, Erin Salo‐Mullen, Ibrahim H. Shah, A. B. Arutyunova, Melissa Batson, Rebecca Gebert, Stacy Pundock, Elizabeth Schofield, Kenneth Offit, Zsofia K. Stadler, Karen A. Cadoo, Maria I. Carlo, Vivek Narayan, Kim A. Reiss, Mark E. Robson, Susan M. Domchek

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: